La présente édition de l’enquête sur la vérification de l’utilisation finale (EUV) des produits de lutte contre le paludisme a été réalisée entre Août 9-31, 2016 sous la direction du Programme National de Lutte contre le Paludisme (PNLP) dans les régions du sud et centre du Mali. L’objectif de l’étude est de contribuer à améliorer la disponibilité, la gestion, et l’utilisation des médicaments et autres intrants antipaludiques dans les structures sanitaires publiques et parapubliques du Mali.
Archive | MalariaRSS feed for this section
Rapport de l’enquête sur la vérification de l’utilisation finale des produits de lutte contre le paludisme au Mali, Août 9-31, 2016
SIAPS supports its country partners by increasing access to effective pharmaceutical products and services and by strengthening pharmaceutical governance. Eliminating stock-outs, avoiding delays, and building human resources and institutional capacity are key to defeating malaria. Below are highlights of some key projects. Building Pharmaceutical Management Capacity in South Sudan Malaria is one of the leading […]
An interview with Andwele Mwansasu, MD, SIAPS Senior Technical Advisor What innovations in fighting malaria over the past five years have particular promise? Has there been a watershed moment? With decreasing malaria burden all over the world, a lot has been happening in the malaria world to sustain these gains. Countries are able to detect […]
Institutionalizing Robust Quantification Processes and Tools within Guinea’s National Malaria Control Program
By Claude Bahati, Deputy Country Project Director, SIAPS, Guinea Accurate quantification for malaria programs, which involves forecasting the quantities needed and planning for the procurement of appropriate pharmaceuticals and supplies, is essential to ensuring that patients receive a continuous supply of commodities. The US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals […]
Pour informer le Ministère de la santé (MS) de la Guinée des besoins du pays et assurer un approvisionnement suffisant en produits antipaludiques, il est essentiel de développer des prévisions précises et reproductibles et un plan d’approvisionnements pour les besoins futurs. A cette fin, le groupe technique – gestion des achats et des stocks (GT-GAS), composé d’acteurs clés venant du Programme national de lutte contre le paludisme (PNLP), de la Pharmacie centrale de la Guinée (PCG), de la Direction nationale de la pharmacie et du médicament (DNPM), de l’Instance de coordination nationale (ICN), de la United States Agency for International Development (USAID) – Guinée, de Systems for Improved Access to Pharmaceutical and Services (SIAPS) et de Catholic Relief Services (CRS), a tenu un atelier de 10 jours pour produire des prévisions de besoins en intrants antipaludiques sur 5 ans et un plan d’approvisionnements sur 3 ans.
By Abraham Ayuen, Senior Communications Specialist for SIAPS South Sudan. This post originally appeared on MSH’s website. Six-year-old Yohana Peter clutched a bottle of mango juice as he waited for his medication outside a pharmacy at Al Sabah Children’s Hospital in Juba, South Sudan. Seated next to his mother on a metal bench, Yohana looked anxious. […]
Technical Brief: Strengthening Drug and Therapeutics Committees to Promote Rational Medicine Use in Mozambique
Mozambique is one of the poorest countries in the world, with approximately 70% of the population living below the poverty line. Many women and children are unable to access essential health services and medicine due to inadequate geographic coverage, financing, and available health professionals. Neonatal mortality is 30 deaths per 1,000, and under-five mortality is 90/1,000. Malaria accounts for approximately 26% of hospital deaths. Dual infections of tuberculosis (TB) and HIV and the threat of increasing multidrug-resistant TB complicate the national TB program response. To support priority programs such as HIV prevention and treatment and maternal and child health, Mozambique’s Ministry of Health and SIAPS are establishing Drug and Therapeutics Committees (DTCs) and training committee members to improve medicine management and use, thereby helping to achieve good health outcomes.
Comprehensive strategies and actions for monitoring the safety of medicines are essential to a well-functioning pharmaceutical sector. The links below highlight recent SIAPS Program work in priority and emerging health issues to strengthen health systems. SIAPS Voices series “You can’t achieve UHC without thinking about gender” In public health, when you’re designing an intervention you’re […]
Systems thinking is now a widely accepted concept in global health. Governments, donors, and other actors in global health recognize that guaranteeing the availability of medicines is a necessary, but insufficient component to improving health outcomes. Rather, medicines availability must be bolstered by other components, such as ensuring that quality medicines are available and prescribed and dispensed appropriately by health care workers; patients must also use medicines properly. In order to achieve improvements in health for their populations and address health inequities, governments and donors must invest in strengthening health systems. A health system depends on its subcomponent, a pharmaceutical system, for the continuous availability of safe, effective, and affordable essential medicines and other health technologies of assured quality to deliver effective health interventions that improve health outcomes. This is in alignment with USAID’s Vision for Health Systems Strengthening (2015-2019). To this end, the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program focuses on achieving positive health outcomes by assuring the availability of quality pharmaceutical products and effective pharmaceutical services.
The Government of South Sudan expends significant resources in the fight against malaria. With support from development partners, it has invested in personnel, infrastructure, and the procurement and distribution of malaria commodities in the country. As one of the key partners supporting government efforts to control malaria, SIAPS has been working to build the capacity of the National Malaria Control Program (NMCP), a government organization responsible for the planning, coordination, and general oversight of all malaria prevention and control activities, including fulfilling Roll Back Malaria and MIS requirements.
To this end, SIAPS has been supporting NMCP in performing its core functions, including planning, coordinating, and implementing malaria interventions. This includes providing on-the-job training and conducting routine supportive supervision; coordinating with other USAID and global health partners to provide malaria case management training; and helping to ensure effective management of essential antimalaria commodities in the country.